UVA, riboflavin cross-linking in treatment of infectious keratitis needs more testing

NEW YORK — UVA and riboflavin cross-linking could be considered for infectious keratitis treatments for better visual outcomes, but more studies are needed, according to a speaker here. Such methods are important to consider because only about half of patients report good visual outcomes when using traditional treatment methods after a corneal infection, Penny A. Asbell, MD, MBA, FACS said at OSN New York 2013. New possibilities also are needed because of increasing multidrug resistance to antibiotics and reduced effectiveness because antibiotic and antifungal agents often do not penetrate tissue (Read more...)

Full Story →